To address this issue, we performed gene expression studies detecting ABCB1, ABCG2, ABCC1, CYP1A2, CYP3A4 and CYP2B6 in systemic and NSCLC cellular models following exposure to tepotinib. The gene discussed is CYP1A2; the disease is non-small cell lung carcinoma.